These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 9303411)

  • 1. Synergistic activities of clarithromycin and pyrazinamide against Mycobacterium tuberculosis in human macrophages.
    Mor N; Esfandiari A
    Antimicrob Agents Chemother; 1997 Sep; 41(9):2035-6. PubMed ID: 9303411
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antituberculosis activity of clarithromycin.
    Luna-Herrera J; Reddy VM; Daneluzzi D; Gangadharam PR
    Antimicrob Agents Chemother; 1995 Dec; 39(12):2692-5. PubMed ID: 8593004
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vitro activities of fourteen antimicrobial agents against drug susceptible and resistant clinical isolates of Mycobacterium tuberculosis and comparative intracellular activities against the virulent H37Rv strain in human macrophages.
    Rastogi N; Labrousse V; Goh KS
    Curr Microbiol; 1996 Sep; 33(3):167-75. PubMed ID: 8672093
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Determination of in vitro synergy when three antimicrobial agents are combined against Mycobacterium tuberculosis.
    Bhusal Y; Shiohira CM; Yamane N
    Int J Antimicrob Agents; 2005 Oct; 26(4):292-7. PubMed ID: 16150578
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synergistic activities of clarithromycin and antituberculous drugs against multidrug-resistant Mycobacterium tuberculosis.
    Cavalieri SJ; Biehle JR; Sanders WE
    Antimicrob Agents Chemother; 1995 Jul; 39(7):1542-5. PubMed ID: 7492101
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The molecular basis of resistance to isoniazid, rifampin, and pyrazinamide in Mycobacterium tuberculosis.
    Somoskovi A; Parsons LM; Salfinger M
    Respir Res; 2001; 2(3):164-8. PubMed ID: 11686881
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Bactericidal therapy in patients with tuberculosis].
    Krasnov VA; Ursov IG
    Probl Tuberk Bolezn Legk; 2004; (3):21-6. PubMed ID: 15338895
    [No Abstract]   [Full Text] [Related]  

  • 8. The Combination Rifampin-Nitazoxanide, but Not Rifampin-Isoniazid-Pyrazinamide-Ethambutol, Kills Dormant Mycobacterium tuberculosis in Hypoxia at Neutral pH.
    Iacobino A; Giannoni F; Pardini M; Piccaro G; Fattorini L
    Antimicrob Agents Chemother; 2019 Jul; 63(7):. PubMed ID: 31010861
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterizing the Effects of Glutathione as an Immunoadjuvant in the Treatment of Tuberculosis.
    Cao R; Teskey G; Islamoglu H; Abrahem R; Munjal S; Gyurjian K; Zhong L; Venketaraman V
    Antimicrob Agents Chemother; 2018 Nov; 62(11):. PubMed ID: 30126957
    [No Abstract]   [Full Text] [Related]  

  • 10. [MICs and MBCs of levofloxacin, clarithromycin, and KRM-1648 for Mycobacterium tuberculosis and M. avium complex residing in MONO-MAC-6 human macrophage-like cell and A-549 human type II alveolar epithelial cell lines].
    Sato K; Ogasawara K; Akaki T; Tomioka H
    Kekkaku; 1999 Jul; 74(7):571-7. PubMed ID: 10481412
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intrinsic resistance of Mycobacterium tuberculosis to clarithromycin is effectively reversed by subinhibitory concentrations of cell wall inhibitors.
    Bosne-David S; Barros V; Verde SC; Portugal C; David HL
    J Antimicrob Chemother; 2000 Sep; 46(3):391-5. PubMed ID: 10980165
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy of macrolides used in combination with ethambutol, with or without other drugs, against Mycobacterium avium within human macrophages.
    Schiavano GF; Celeste AG; Salvaggio L; Sisti M; Brandi G
    Int J Antimicrob Agents; 2001 Dec; 18(6):525-30. PubMed ID: 11738339
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pyrazinamide is not active against Mycobacterium tuberculosis residing in cultured human monocyte-derived macrophages.
    Heifets L; Higgins M; Simon B
    Int J Tuberc Lung Dis; 2000 Jun; 4(6):491-5. PubMed ID: 10864178
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Susceptibility testing of Mycobacterium tuberculosis to pyrazinamide.
    The Editors
    J Med Microbiol; 2002 Jan; 51(1):11-12. PubMed ID: 11800467
    [No Abstract]   [Full Text] [Related]  

  • 15. Bacteriostatic and bactericidal activities of benzoxazinorifamycin KRM-1648 against Mycobacterium tuberculosis and Mycobacterium avium in human macrophages.
    Mor N; Simon B; Heifets L
    Antimicrob Agents Chemother; 1996 Jun; 40(6):1482-5. PubMed ID: 8726023
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Experimental evidence for Mycobacterium tuberculosis persistence in M. tuberculosis-infected H37RV mice in the treatment with 3 first-line drugs (rifampicin, isoniazid, pyrazinamide)].
    Smirnova TG; Chernousova LN; Andreevskaia SN; Nikolaeva GM
    Probl Tuberk Bolezn Legk; 2004; (3):32-7. PubMed ID: 15338898
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intramacrophage passage of Mycobacterium tuberculosis and M. avium complex alters the drug susceptibilities of the organisms as determined by intracellular susceptibility testing using macrophages and type II alveolar epithelial cells.
    Tomioka H; Sato K; Sano C; Sano K; Shimizu T
    Antimicrob Agents Chemother; 2002 Feb; 46(2):519-21. PubMed ID: 11796367
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pyrazinamide Is Active against Mycobacterium tuberculosis Cultures at Neutral pH and Low Temperature.
    den Hertog AL; Menting S; Pfeltz R; Warns M; Siddiqi SH; Anthony RM
    Antimicrob Agents Chemother; 2016 Aug; 60(8):4956-60. PubMed ID: 27270287
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Activity of ketoconazole against Mycobacterium tuberculosis in vitro and in the mouse model.
    Byrne ST; Denkin SM; Gu P; Nuermberger E; Zhang Y
    J Med Microbiol; 2007 Aug; 56(Pt 8):1047-1051. PubMed ID: 17644711
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of activities of rifapentine and rifampin against Mycobacterium tuberculosis residing in human macrophages.
    Mor N; Simon B; Mezo N; Heifets L
    Antimicrob Agents Chemother; 1995 Sep; 39(9):2073-7. PubMed ID: 8540718
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.